| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 42,633 | 20,784 | ||
| Marketable securities | 139,774 | 154,700 | ||
| Prepaid expenses and other current assets | 2,520 | 1,355 | ||
| Total current assets | 184,927 | 176,839 | ||
| Property and equipment, net | 880 | 856 | ||
| Other long-term assets | 266 | 186 | ||
| Operating lease right-of-use assets | 4,774 | 5,007 | ||
| Total assets | 190,847 | 182,888 | ||
| Accounts payable | 786 | 2,001 | ||
| Accrued expenses | 4,098 | 3,747 | ||
| Current portion of operating lease liabilities | 1,477 | 1,466 | ||
| Total current liabilities | 6,361 | 7,214 | ||
| Operating lease liabilities, net of current portion | 4,016 | 4,284 | ||
| Total liabilities | 10,377 | 11,498 | ||
| Common stock-Common Class A | 23 | 19 | ||
| Common stock-Common Class B | 6 | 7 | ||
| Additional paid-in-capital | 342,400 | 320,649 | ||
| Accumulated deficit | -162,224 | -149,432 | ||
| Accumulated other comprehensive income | 265 | 147 | ||
| Total stockholders' equity | 180,470 | 171,390 | ||
| Total liabilities and stockholders' equity | 190,847 | 182,888 | ||
Contineum Therapeutics, Inc. (CTNM)
Contineum Therapeutics, Inc. (CTNM)